|
Jun 16
|
Exploring High Growth Tech Stocks In The US This June 2025
|
|
Jun 11
|
The European Commission Approves Alnylam’s AMVUTTRA
|
|
Jun 11
|
Instil Bio Names John Maraganore, Ph.D., to Board Role Supporting the Advancement of PD-L1xVEGF Bispecific Antibody Program
|
|
Jun 10
|
Alnylam Wins EC Nod for Label Expansion of Amvuttra for ATTR-CM
|
|
Jun 10
|
EC approves Alnylam’s vutrisiran for ATTR-CM treatment
|
|
May 24
|
3 High-Flying Stocks That Could Soar Even More
|
|
May 20
|
Alnylam Issues 2024 Corporate Responsibility Report
|
|
Apr 17
|
Alnylam to Webcast Conference Call Discussing First Quarter 2025 Financial Results
|
|
Mar 14
|
Alnylam Rallies 62% in a Year: Can the Stock Maintain This Momentum?
|
|
Mar 11
|
Alnylam to Webcast Presentation at Stifel 2025 Virtual CNS Forum
|
|
Feb 27
|
Q4 2024 Vir Biotechnology Inc Earnings Call
|
|
Feb 25
|
Alnylam Highlights Significant Pipeline Progress and Platform Innovation at R&D Day
|
|
Feb 18
|
SNY and REGN's Dupixent sBLA for Skin Disease Gets FDA's Priority Tag
|
|
Feb 14
|
Alnylam Q4 Earnings Beat Estimates, Product Revenues Rise Y/Y
|
|
Feb 14
|
Alnylam Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations
|
|
Feb 14
|
Alnylam Pharmaceuticals Inc (ALNY) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...
|
|
Feb 14
|
Q4 2024 Alnylam Pharmaceuticals Inc Earnings Call
|
|
Feb 13
|
Alnylam (ALNY) Reports Q4 Earnings: What Key Metrics Have to Say
|
|
Feb 13
|
Alnylam Pharmaceuticals (ALNY) Beats Q4 Earnings and Revenue Estimates
|
|
Feb 13
|
Alnylam: Q4 Earnings Snapshot
|